Laura Gramantieri

University of Bologna

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (9)

Carlos Sanchez Martin

Associate Professor (RTT)

University of Rome Tor Vergata

ITALY

View details

Simone Merlin

Associate professor

Università degli Studi del Piemonte Orientale

ITALY

View details

Fabio Piscaglia

University of Bologna

ITALY

View details

Carlos Sebastian

SPAIN

View details

sara erika bellomo

Candiolo Cancer Institute, FPO-IRCCS

ITALY

View details

FRANCESCO TOVOLI

Assistant Professor

University of Bologna

ITALY

View details

DAVIDE TRERE'

Full Professor

University of Bologna

ITALY

View details

Massimo NEGRINI

Professor

University of Ferrara

ITALY

View details

Francesca Fornari

University of Bologna

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Laura Gramantieri

Research Interests

Explore related searches

Contact this professor

Articles (10)

Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma

MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma

Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area

Notch Signaling Regulation in HCC: From Hepatitis Virus to Non-Coding RNAs

Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming

Direct Antiviral Treatments for Hepatitis C Virus Have Off-Target Effects of Oncologic Relevance in Hepatocellular Carcinoma

MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma

Association of NOS3 and ANGPT2 gene polymorphisms with survival in patients with hepatocellular carcinoma receiving sorafenib: Results of the multicenter prospective INNOVATE study

Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma (Targeted Oncology, (2020), 15, 6, (773-785), 10.1007/s11523-020-00757-3)

Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma

Collaborators (9)

Carlos Sanchez Martin

Simone Merlin

Fabio Piscaglia

Carlos Sebastian

sara erika bellomo

FRANCESCO TOVOLI

DAVIDE TRERE'

Massimo NEGRINI

Francesca Fornari

Make your next move.